Trials / Sponsors / Epigenomics, Inc
Epigenomics, Inc
Industry · 9 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Plasma-based Colorectal Cancer Screening Research & Development Colo-rectal Cancer | — | 2019-05-03 |
| Completed | HCCBloodTest for Detection of Hepatocellular Carcinoma (HCC) Cirrhosis, Liver, Hepatic Cirrhosis, Hepatocellular Carcinoma | — | 2018-12-17 |
| Unknown | Longitudinal Performance of Epi proColon Colorectal Cancer, Colorectal Neoplasms | — | 2017-08-18 |
| Completed | Adherence to Minimally Invasive Testing Colorectal Cancer | — | 2014-10-01 |
| Withdrawn | Assessment of Septin9 Biomarker for Detection of Colorectal Cancer in Patients With Positive Fecal Immunochemi Colorectal Cancer | — | 2012-06-01 |
| Completed | Head to Head Study Epi proColon and FIT Colorectal Cancer | — | 2012-03-01 |
| Completed | Specimens for Septin 9 Performance Colorectal Cancer | EARLY_Phase 1 | 2011-05-01 |
| Completed | PRESEPT Study: Evaluation of SEPT9 Biomarker Performance for Colorectal Cancer Screening Colorectal Cancer | — | 2008-06-01 |
| Completed | Detection of Colorectal Cancer in Peripheral Blood by Septin 9 DNA Methylation Assay Colorectal Cancer | — | 2005-01-01 |